目的 评价护理风险管理在糖尿病(DM)合并恶性肿瘤患者化疗中的临床意义.方法 将实施风险护理管理后的109例DM合并恶性肿瘤化疗患者作为观察组,未实施护理风险管理前的87例该病患者作为对照组,分别观察患者DM急性并发症发生情况、化疗药物外渗的发生情况及患者满意度,探讨实施护理风险管理的具体措施.结果 实施护理风险管理后DM合并恶性肿瘤化疗患者的DM急性并发症发生率、化疗药物外渗情况及患者满意度均优于对照组,差异有统计学意义(P<0.05).结论 护理风险管理在DM合并恶性肿瘤患者化疗中具有较好的临床意义和应用价值,提高了护理质量,值得推广使用.%Objective To appraise the clinical meaning of nursing risk management in chemotherapy of diabetes with malignant tumor. Methods 109 patients were enforced by nursing risk management (observe group) ,87 patients were not enforced by nursing risk management (control group). We compared the incidence of diabetes acute complication,chemotherapeutics exosmosis,and sat isfaction degree of patient,and then discuss the exact measures of nursing risk management. Results The incidence of diabetes a cute complication and chemotherapeutics exosmosis were all significantly lower in observe group than control group,satisfaction de gree of patient was significantly higher in observe group than control group (P<0. 05). Conclusion Nursing risk management was efficient in the chemotherapy of diabetes with malignant tumor and worth promotion.
展开▼
机译:随机,安慰剂对照,FosapRepitant,Ondansetron,Dexamethasone(喜欢的)与Fond Plus Olanzapine(FONE-O)进行血液学恶性肿瘤患者的血液学恶性肿瘤患者呕吐,ondansetron,ondansetron(Fond-O)的试验。接受高均匀化疗和造血细胞移植的血液学恶性肿瘤患者 方案:FOND-O试验
机译:随机,安慰剂对照,FosapRepitant,Ondansetron,Dexamethasone(喜欢的)与Fond Plus Olanzapine(FONE-O)进行血液学恶性肿瘤患者的血液学恶性肿瘤患者呕吐,ondansetron,ondansetron(Fond-O)的试验。接受高均匀化疗和造血细胞移植的血液学恶性肿瘤患者方案:FOND-O试验